No Data
Kangzhong Healthcare: Kangzhong Healthcare 2024 Annual Results Express Announcement
Kangzhong Medical 2024 Annual Results Express Announcement
Kangzhong Medical (688607.SH): In 2024, the net income is 17.4807 million yuan, an increase of 13.42% year-on-year.
On February 24, Glonghui reported that Kangzhong Medical (688607.SH) released its annual performance report for 2024, showing a total revenue of 293.9007 million yuan during the reporting period, an increase of 7.36% compared to the same period last year. The main reason for this is the company's steady advancement of the application and transformation of new products and technologies, enriching the product line, strengthening market promotion, and enhancing product competitiveness, while also increasing the development efforts for new products, comprehensively driving steady growth in revenue. During the reporting period, the company achieved an operating profit of 16.5649 million yuan, an increase of 2.7311 million yuan compared to the same period last year; total profit reached 1,719.
Kangzhong Medical (688607.SH): Main products are widely used in the Medical, industrial/security and other fields.
On January 17, Glodon reported that Kangzhong Medical (688607.SH) stated on the investor interaction platform that the company's main products are widely used in Medical, Industrial/Safety inspection and other fields. Among them, in the Industrial/Safety inspection sector, the company's products can be applied in various scenarios such as New Energy Fund power Battery testing, Semiconductors testing, and industrial non-destructive testing, as well as safety inspection and bomb disposal checks. For specific Business information, please refer to the company's publicly disclosed relevant materials.
Kangzhong Medical (688607.SH): Changcheng and Junlian Chengyu collectively reduced their shareholding of the company by 1.13%.
Kangzhong Medical (688607.SH) announced that Changcheng and Junlian Chengyu conducted large-scale trades and centralized bidding...
Kangzhong Healthcare Third Quarter Report 2024
